CHUC Announces $2 Million Financing to Fuel Expansion of "Nicotine-Free" E-Cigarette SBX

Aug.28.2025
CHUC Announces $2 Million Financing to Fuel Expansion of "Nicotine-Free" E-Cigarette SBX
Charlie's Holdings, Inc. (CHUC) secured a $2 million credit agreement with independent director Michael D. King to expand its nicotine-free SBX product. Early sales in the U.S. Southeast exceeded expectations, with the product being legal and popular nationwide. Funds will boost inventory and convenience store presence. CHUC has also sold 16 PACHA-related assets to Reynolds in three deals.

Key points:

 

·Market Performance: CHUC stated that sales of SBX products in several regions in the southeast exceeded company expectations. Non-nicotine SBX products are legal in most parts of the United States and are popular among adult users. 

·Credit Support: CHUC received $2 million in credit support from independent director Michael D. King, with the funds being disbursed in three installments over a 12-month period at a 13% interest rate. 

·Market Performance: CHUC stated that sales of SBX products in several regions in the southeast exceeded company expectations. Non-nicotine SBX products are legal in most parts of the United States and are popular among adult users. 

·User Preferences: CHUC reported that non-nicotine SBX disposable products are preferred over Juul tobacco e-cigarette products by a ratio of 15:1. 

·External Collaboration: CHUC has sold assets related to PACHA products to Reynolds, a subsidiary of British American Tobacco, in three transactions totaling 16 assets.

 


 

According to a report from Access Newswire on August 26, Charlie's Holdings, Inc. (OTCQB: CHUC) announced that the company has entered into a highly favorable $2 million credit agreement with Michael D. King, an independent director on Charlie's board who currently holds over 2.5% of the company's shares.

 

CHUC stated that early sales of SBX in several southeastern regions have exceeded the company's expectations. SBX, which does not contain nicotine (Metatine, which is actually a form of nicotine known as 6-Methyl Nicotine), provides adult users of traditional e-cigarette products or combustible cigarettes with a unique new option that allows them to enjoy the taste of traditional nicotine products. The product is legal in most areas of the United States.

 

CHUC also stated that in a sponsored focus group study targeting adult e-cigarette product users, Charlie's nicotine-free SBX disposable product was preferred over Juul's tobacco-flavored e-cigarette product at a ratio of 15:1.

 

In order to facilitate an increase in SBX inventory purchases and drive the company's growth in the mass market convenient store channels, Michael has agreed to borrow up to $2 million from Charlie at an interest rate of 13% (to be disbursed in three installments). Each loan will have a term of 12 months, with interest and principal repayment due on the first anniversary of each loan disbursement.

 

Therefore, with the initial $1 million loan and subsequent two $500,000 loans, this debt/credit instrument gives the company the discretion to borrow as needed to meet the growing demands of the SBX product line. This credit instrument is non-convertible to equity, does not include warrants, and is extremely favorable to the company.

 

In addition, Michael has expressed willingness to consider providing additional loans in the coming months if the company's sales situation requires.

 

We are fortunate to have encountered the challenge of needing more funds to meet the demands of the SBX market... We are determined to grow cautiously," explained President Charlie Henry Sicignano.

 

Despite being in a position where most public companies may initiate dilutive equity financing, take on convertible debt, or borrow at high-interest rates from private lenders, Chief Operating Officer Ryan Stump and I are determined to secure the best financing terms for Charlie. In fact, we believe that Michael Jin's credit tools will be extremely beneficial to CHUC shareholders.

 

Michael commented, "CHUC has a striking strategic plan, a solid competitive advantage, and a management team with more favorable interests compared to any other publicly traded company I know of. I look forward to CHUC being listed on the national stock exchange... hopefully at a higher market value. Henry and Ryan will have my unwavering support.

 

Prior to this, CHUC had already announced the completion of a third asset transaction with Reynolds e-cigarette company, a subsidiary of British American Tobacco. The latter acquired an additional PACHA product and its related assets from CHUC for $1 million, including the PMTA application submitted for the first time in 2022. Statistics show that Reynolds e-cigarette company has now acquired a total of 16 related assets from CHUC.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Australia’s TGA Places Nicotine Pouches Under Therapeutic Goods Rules From July 24, Blocking Imports of Unapproved Products
Australia’s TGA Places Nicotine Pouches Under Therapeutic Goods Rules From July 24, Blocking Imports of Unapproved Products
Australia is strengthening controls on nicotine pouches under its existing therapeutic goods regulatory framework. According to the Therapeutic Goods Administration (TGA), nicotine pouch products must meet regulatory requirements, and unapproved products cannot be legally imported. The move follows Australia’s broader approach of maintaining strict oversight of nicotine products, including nicotine-containing vapes. As nicotine pouches expand globally, Australia’s regulatory approach highlights growing differences in how countries manage emerging smoke-free nicotine products.
Regulations
Jul.27
EU Tobacco Rules Face Pushback as Analysis Says 90% of Consultation Responses Raised Objections
EU Tobacco Rules Face Pushback as Analysis Says 90% of Consultation Responses Raised Objections
An analysis by We Are Innovation says more than 90% of over 82,000 responses to the European Commission’s public consultation on the Tobacco Products Directive revision raised at least one substantial objection to the proposed regulatory direction.
Jul.13
Product | IVG Pro 15K Enters European Retail Channels, Expanding High-Capacity Pod System Segment
Product | IVG Pro 15K Enters European Retail Channels, Expanding High-Capacity Pod System Segment
UK vape brand IVG has introduced the IVG Pro 15K, a high-capacity pod system combining a 2ml prefilled pod with a 10ml refill container to deliver up to 15,000 puffs. Unlike conventional high-puff disposable vapes, the IVG Pro 15K adopts a reusable device structure, reflecting a broader shift in the European vape market toward longer-use-cycle products and reusable hardware ecosystems.
Jul.14
Australia’s Daily Smoking Rate Falls to Record Low of 5.8% as Nicotine Use Patterns Shift
Australia’s Daily Smoking Rate Falls to Record Low of 5.8% as Nicotine Use Patterns Shift
According to the Australian Institute of Health and Welfare’s National Drug Strategy Household Survey, daily smoking among Australians aged 18 and over fell to a record low of 5.8% in 2025. Health Minister Mark Butler said Australia now has around 500,000 fewer daily smokers than three years ago and credited the government’s vaping reforms as part of broader progress. Among people aged 14 and over, daily smoking declined from 8.3% in 2022-23 to 5.6% in 2025. Daily vaping rates stabilised at 3.6%, while the government also moved to further restrict access to nicotine pouches through unapproved therapeutic import pathways.
Jul.21
Product | Vapsolo Launches Sixer 180K, Introducing a 6-in-1 Architecture for Disposable Vapes
Product | Vapsolo Launches Sixer 180K, Introducing a 6-in-1 Architecture for Disposable Vapes
Vapsolo has launched the Sixer 180K, a flagship disposable vape built around a 6-in-1 architecture featuring six independent e-liquid tanks and six dedicated mesh coils. Alongside a claimed up to 180,000 puffs, the new device reflects a broader shift in disposable vape development from increasing puff counts toward modular hardware design and multi-flavor user experience.
Jul.03
U.S. FDA: Youth E-Cigarette Prevention Campaign Prevented About 444,000 Initiations and Reduced Illegal Vape Sales
U.S. FDA: Youth E-Cigarette Prevention Campaign Prevented About 444,000 Initiations and Reduced Illegal Vape Sales
The U.S. Food and Drug Administration (FDA) said its youth e-cigarette prevention campaign, “The Real Cost,” prevented about 444,000 U.S. youth from starting e-cigarette use between 2023 and 2024 and blocked more than $42 million in unauthorized e-cigarette sales that would have been used by youth.
Market
Jun.25